ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 132,49
0,46%
Dow Jones
39 069,59
0,01%
DAX
18 774,71
0,43%
Brent Oil
82,845
1,06%
Bitcoin
69 558,70
1,53%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Interpace Biosciences Inc (IDXG)

  7. Interpace Biosciences Inc (IDXG) Actualités

IDXG

Interpace Biosciences (IDXG)

Interpace Biosciences Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:IDXG
DateHeureSourceTitreSymboleSociété
12/05/202322h35Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDXGInterpace Biosciences Inc
12/05/202322h24Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:IDXGInterpace Biosciences Inc
03/05/202321h17Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:IDXGInterpace Biosciences Inc
28/04/202322h20Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:IDXGInterpace Biosciences Inc
27/03/202322h40Edgar (US Regulatory)Annual Report (10-k)NASDAQ:IDXGInterpace Biosciences Inc
14/11/202222h41GlobeNewswire Inc.Interpace Biosciences Announces Third Quarter 2022 Financial and Business Results Sale of Pharma Significantly Improves Liquidity Resulting in Removal of Going ConcernNASDAQ:IDXGInterpace Biosciences Inc
20/10/202222h28GlobeNewswire Inc.Interpace Biosciences Announces New Real-world Data; Presented at the American Thyroid Association 2022 Annual MeetingNASDAQ:IDXGInterpace Biosciences Inc
20/09/202222h47Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:IDXGInterpace Biosciences Inc
20/09/202222h37Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:IDXGInterpace Biosciences Inc
09/09/202222h29Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:IDXGInterpace Biosciences Inc
01/09/202223h18GlobeNewswire Inc.Interpace Biosciences Announces New Clinical Validation Data; Diagnostic Accuracy Significantly ImprovedNASDAQ:IDXGInterpace Biosciences Inc
31/08/202223h30GlobeNewswire Inc.Interpace Biosciences Completes Sale of Its Pharma Services Business to Flagship Biosciences, Inc.NASDAQ:IDXGInterpace Biosciences Inc
15/08/202222h05GlobeNewswire Inc.Interpace Biosciences Announces Second Quarter 2022 Financial and Business Results and New Clinical Validation Data; Diagnostic Accuracy Significantly ImprovedNASDAQ:IDXGInterpace Biosciences Inc
16/05/202222h15GlobeNewswire Inc.Interpace Biosciences Announces First Quarter 2022 Financial and Business ResultsNASDAQ:IDXGInterpace Biosciences Inc
11/05/202214h30GlobeNewswire Inc.Miroculus to Optimize Automated Next Generation Sequencing Library Preparation with Interpace Diagnostics and Twist BioscienceNASDAQ:IDXGInterpace Biosciences Inc
08/04/202212h15TipRanksAnalysts Offer Insights on Healthcare Companies: Interpace Diagnostics Group (OtherIDXG) and Biogen (BIIB)NASDAQ:IDXGInterpace Biosciences Inc
31/03/202222h15GlobeNewswire Inc.Interpace Biosciences Announces Full Year and Fourth Quarter 2021 Financial and Business ResultsNASDAQ:IDXGInterpace Biosciences Inc
22/02/202215h00GlobeNewswire Inc.Interpace Biosciences Announces Update of Previously Announced CMS Billing Policy Impacting its Thyroid TestsNASDAQ:IDXGInterpace Biosciences Inc
02/02/202222h04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDXGInterpace Biosciences Inc
01/02/202216h16Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:IDXGInterpace Biosciences Inc
29/01/202201h35GlobeNewswire Inc.Interpace Biosciences Terminates Rights Offering Announces Change in CMS Medicare Reimbursement of its Thyroid TestsNASDAQ:IDXGInterpace Biosciences Inc
27/01/202222h05GlobeNewswire Inc.Interpace Biosciences Announces Appointment of Vijay Aggarwal, Ph.D. as New DirectorNASDAQ:IDXGInterpace Biosciences Inc
13/01/202212h05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:IDXGInterpace Biosciences Inc
13/01/202212h05Edgar (US Regulatory)Post-effective Amendment Filed Solely to Add Exhibits to a Registration Statement (pos Ex)NASDAQ:IDXGInterpace Biosciences Inc
12/01/202222h41GlobeNewswire Inc.Interpace Biosciences Announces Commencement of Fully Back-Stopped $30 Million Rights OfferingNASDAQ:IDXGInterpace Biosciences Inc
03/01/202223h07GlobeNewswire Inc.Interpace Biosciences Announces Record Date for Proposed Fully Back-Stopped $30 Million Rights OfferingNASDAQ:IDXGInterpace Biosciences Inc
10/11/202122h05GlobeNewswire Inc.Interpace Biosciences Announces Third Quarter 2021 Financial and Business ResultsNASDAQ:IDXGInterpace Biosciences Inc
02/11/202121h15GlobeNewswire Inc.Interpace Biosciences Announces New $8 Million Term Loan with BroadOak Capital Partners and Repayment of Private Equity LoansNASDAQ:IDXGInterpace Biosciences Inc
28/10/202114h15GlobeNewswire Inc.Interpace Biosciences Announces U.S. PTO Issuance of Patent No. 11,143,657 Titled: Topographic Genotyping for Determining the Diagnosis, Malignant Potential, and Biologic Behavior of Pancreatic Cysts and Related ConditionsNASDAQ:IDXGInterpace Biosciences Inc
21/10/202115h15GlobeNewswire Inc.Interpace Diagnostics Announces US Patent Approval for Patent Application No. 11,118, 231 B2 Titled: microRNAs as Biomarkers for Distinguishing Benign from Malignant Thyroid NeoplasmsNASDAQ:IDXGInterpace Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:IDXG

Dernières Valeurs Consultées

AQSE
ATC
All Things Considered
LSE
0K10
Mettler-toledo
LSE
0R1G
Home Depot
UNSW
STACKETH
StackOS
BIT
F15622
Vontobel Financial Produ...
NASDAQ
LGIOX
Lord Abbett Mid Cap Inno...
BITV
BSVEUR
Bitcoin SV
USOTC
SAPX
Seven Arts Entertainment (PK)
MRTX
BDTBTC
Bitdepositary
LSE
SALT
Microsalt
LSE
FCX
BIT
F17719
Vontobel Financial Produ...
NASDAQ
DCTM
Documentum
USOTC
ISOL
Image Software (CE)
USOTC
WTII
Water Technologies (PK)
ASX
SIGKOB
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés